Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Calavo Growers (CVGW) Capital Expenditures (2016 - 2026)

Calavo Growers (CVGW) has 16 years of Capital Expenditures data on record, last reported at -$308000.0 in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 87.52% year-over-year to -$308000.0; the TTM value through Oct 2025 reached $11000.0, down 78.43%, while the annual FY2025 figure was $11000.0, 78.43% down from the prior year.
  • Capital Expenditures reached -$308000.0 in Q4 2025 per CVGW's latest filing, down from $85000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $9.8 million in Q4 2023 and bottomed at -$7.6 million in Q3 2023.
  • Average Capital Expenditures over 5 years is $1.0 million, with a median of $212000.0 recorded in 2024.
  • Peak YoY movement for Capital Expenditures: skyrocketed 3323.81% in 2022, then plummeted 292.15% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at -$63000.0 in 2021, then surged by 3323.81% to $2.0 million in 2022, then skyrocketed by 383.75% to $9.8 million in 2023, then plummeted by 125.12% to -$2.5 million in 2024, then soared by 87.52% to -$308000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were -$308000.0 in Q4 2025, $85000.0 in Q3 2025, and -$48000.0 in Q2 2025.